References
A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, J.H.H. Thijssen, Reprint of classification and pharmacology of progestins. Maturitas 61(1–2), 171–180 (2008). doi:10.1016/j.maturitas.2008.11.013
V. Hug, S. Kau, G.N. Hortobagyi, L. Jones, Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. Br. J. Cancer 63(3), 454–456 (1991)
L. Anttila, P. Koskinen, H.L. Kaihola, R. Erkkola, K. Irjala, K. Ruutiainen, Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries. Fertil. Steril. 58(4), 697–702 (1992)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have nothing to declare as a conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Seo, Y., Jeong, E.G. & Kim, E.S. Cushing’s syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome. Endocrine 50, 519–521 (2015). https://doi.org/10.1007/s12020-015-0722-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0722-7